Boston Scientific (NYSE:BSX) Price Target Raised to $78.00 at Evercore ISI

Boston Scientific (NYSE:BSX – Free Report) had its price target upped by Evercore ISI from $72.00 to $78.00 in a research report report published on Thursday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. A number of other research analysts have also weighed in on BSX. Mizuho raised […]

Related Keywords

Canada ,Boston ,Massachusetts ,United States ,Raymond James ,John Bradley Sorenson ,Wendy Carruthers ,Jones Financial Companies Lllp ,Bruceg Allen Investments ,Investment Counselors ,Wells Fargo Company ,Boston Scientific Corporation ,Securities Exchange Commission ,Boston Scientific ,Frazier Financial Advisors ,Royal Bank ,Free Report ,Moderate Buy ,Get Free Report ,Bradley Sorenson ,Exchange Commission ,Financial Advisors ,Financial Companies Lllp ,Scientific Corporation ,Boston Scientific Daily ,Nyse Bsx ,Bsx ,Medical ,10113710 ,Boost Price Target ,Evercore Isi ,